MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
source: myfinsight.com
Net increase
(decrease)
-$3,705,144
Non-cash operating lease
cost
$122,553
Stock-based compensation
expense
$82,176
Fair value of shares
issued for services
$53,400
Operating lease liability
$22,813
Research and development
contract liabilities
$6,297
something is missing
-$1,848,922
Net cash used in
operating activities
-$1,831,363
Net cash used in
investing activities
-$24,859
Canceled cashflow
$287,239
Net loss
-$1,987,608
Capitalized costs for light
equipment
$24,859
Other prepaid
expenses
$56,244
Accounts payable and
accrued expenses
-$45,401
Prepaid insurance
$29,349
Back